Satellos Bioscience Inc
XTSX:MSCL
Balance Sheet
Balance Sheet Decomposition
Satellos Bioscience Inc
Satellos Bioscience Inc
Balance Sheet
Satellos Bioscience Inc
| Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
2
|
1
|
0
|
1
|
0
|
5
|
2
|
|
| Cash Equivalents |
2
|
1
|
0
|
1
|
0
|
5
|
2
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
2
|
1
|
0
|
1
|
1
|
5
|
2
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
7
|
4
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
2
N/A
|
1
-44%
|
0
-87%
|
1
+724%
|
1
-63%
|
13
+2 203%
|
6
-51%
|
|
| Liabilities | ||||||||
| Accounts Payable |
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
1
|
1
|
1
|
2
|
3
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
+109%
|
1
+178%
|
1
+1%
|
1
+61%
|
2
+62%
|
3
+35%
|
|
| Equity | ||||||||
| Common Stock |
28
|
28
|
28
|
30
|
30
|
28
|
30
|
|
| Retained Earnings |
29
|
30
|
33
|
36
|
37
|
20
|
30
|
|
| Additional Paid In Capital |
4
|
4
|
4
|
6
|
7
|
2
|
3
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
2
N/A
|
1
-53%
|
1
N/A
|
1
N/A
|
1
N/A
|
10
N/A
|
3
-68%
|
|
| Total Liabilities & Equity |
2
N/A
|
1
-44%
|
0
-87%
|
1
+724%
|
1
-63%
|
13
+2 203%
|
6
-51%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
4
|
4
|
4
|
8
|
8
|
33
|
42
|
|